Intravenous infusions of serotonin (5-hydroxtryptamine creatinine sulphate, 5HT, 50-300 μg/kg/min) in cats reversibly inhibited the responses of cervical spinal cord neurons to electrical stimulation of the superior sagittal sinus. Inhibition developed over 20-30 min and resolved over the same time course, suggesting a dependence on accumulation of 5HT in the central nervous system. Inhibition was suppressed by prior intravenous injection of the 5HT antagonists methysergide (1 mg/kg) and methiothepin (1 mg/ kg). Infusions of 5HT (50 μg/kg/min) caused a rise in whole blood levels of 5HT by a factor of 1.5 of control values. 5HT levels in platelet-free plasma rose by a factor of 50. Levels of 5HT and 5 hydroxyindole acetic acid released into the cerebrospinal fluid rose significantly. The results suggest that earlier clinical observations that 5HT infusions can ameliorate the pain of migraine may not have been due to cranial vasoconstriction alone, but could have involved a central action of 5HT.
KimballRWFriedmanAPVallejoEEffect of serotonin in migraine patients.Neurology1960;
10:
107–11
2.
AnthonyMHinterbergerHLanceJWPlasma serotonin in migraine and stress.Arch Neurol1967;
16:
544–52
3.
HopfHCJohnsonEAGutmannLProtective effect of serotonin on migraine attacks.Neurology1992;
42:
1419
4.
SpiraPJMylecharaneEJLanceJWThe effects of humoral agents and antimigraine drugs on the cranial circulation of the monkey.Res Clin Stud Headache1976;
4:
37–75
5.
LambertGMichalicekJEffect of antimigraine drugs on dural blood flows and resistances and the responses to trigeminal stimulation.Eur J Pharmacol1996;
311:
141–51
6.
HumphreyPPAConnorHEStubbsCMFeniukWEffect of sumatriptan on pial vessel diameter in vivo. In:
OlesenJ, editor.
Migraine and other headaches. The vascular mechanisms.
New York:
Raven Press,
1991:
335–8
7.
MoskowitzMANeurogenic inflammation in the pathophysiology and treatment of migraine.Neurology1993;
43Suppl 3:
S16–20
8.
LambertGALowyAJBoersPMAngus-LeppanHZagamiASThe spinal cord processing of input from the superior sagittal sinus: pathway and modulation by ergot alkaloids.Brain Res1992;
597:
321–30
9.
CumberbatchMJHillRGHargreavesRJRizatriptan has central antinociceptive effects against durally evoked responses.Eur J Pharmacol1997;
328:
37–40
10.
CumberbatchMJHillRGHargreavesRJDifferential effects of naratriptan on spinal vs trigeminal nociceptive responses.Cephalalgia1997;
17:
381
11.
GoadsbyPJKnightYInhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxytryptamine (5HT1B/1D) receptors.Br J Pharmacol1997;
122:
918–22
12.
KaubeHHoskinKLGoadsbyPJInhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption.Br J Pharmacol1993;
109:
788–92
13.
CumberbatchMJHillRGHargreavesRJThe effects of 5HT1A, 5HT1B and 5HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats.Eur J Pharmacol1998;
362:
43–6
14.
LambertGAShimomuraTBoersPGordonVZagamiASIntravenous infusions of serotonin suppress responsiveness of second order trigeminovascular sensory neurons.Cephalalgia1997;
17:
380
15.
GoadsbyPJHoskinKLSerotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT(1B/1D) receptor—a central action in migraine.Ann Neurol1998;
43:
711–8
16.
HuJWDostrovskyJOSessleBJFunctional properties of neurons in cat trigeminal suhnucleus caudalis (medullary dorsal horn). I. Responses to oral-facial noxious and nonnoxious stimuli and projections to thalamus and subnucleus caudalis.J Neurophysiol1981;
45:
173–91
17.
NaglerJConfortiNFeldmanSAlterations produced by cortisol in the spontaneous activity and responsiveness to sensory stimulation of single cells in the tuberal hypothalamus of the rat.Neuroendocrinology1973;
12:
52–6
18.
Da PradaMPicottiGBContent and subcellular localisation of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma.Br J Pharmacol1979;
65:
653–62
19.
FeldbergWSherwoodSLA permanent cannula for intraventricular injections in cats.J Physiol1953;
120:
3P
20.
MerlisJKThe effect of changes in the calcium content of the cerebrospinal fluid on spinal reflex activity in the dog.Am J Physiol1940;
131:
67–72
21.
HelkeCJDias SouzaJGillisRAInteraction of serotonin and deslanoside on cardiac rhythm in the cat.Eur J Pharmacol1978;
51:
167–77
22.
HumphreyJHJaquesRThe histamine and serotonin content of the platelets and polymorphonuclear leucocytes of various species.J Physiol1954;
124:
305–10
23.
SmithGSmithANThe role of serotonin in experimental pulmonary embolism.Surg Gynecol Obstet1955;
101:
691–9
24.
SandersRWaalkesTPGilbertJWTerryLLSerotonin (5-hydroxytryptamine) and pulmonary thromboembolism.Surg Gynecol Obstet1959;
30:
455–9
25.
RossSBAperiaBBeck-FriisJJansaSWetterbergLAbergAInhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo.Psychopharmacology1980;
67:
1–7
26.
ChengF-CYangL-LChangF-MChiaL-GKuoJ-SSimultaneous measurement of serotonin, catecholamines and their metabolites in cat and human plasma by in vitro microdialysis-microbore high-performance liquid chromatography with amperometric detection.J Chromatogr1992;
582:
19–27
27.
PetterssonGAhlmanHBhargavaHNDahlstromAKewenterJLarssonIThe effect of propranolol on the serotonin concentration in the portal plasma after vagal nerve stimulation in the cat.Acta Physiol Scand1979;
107:
327–31
28.
FerrariMDOdinkJTapparelliCVanKGPenningsEJBruynGWSerotonin metabolism in migraine.Neurology1989;
39:
1239–42
29.
AnthonyMLanceJWPlasma serotonin in patients with chronic tension headaches.J Neurol Neurosurg Psychiatry1989;
52:
182–4
30.
MezzanoSKunickMOlavarriaFArdilesLArandaEMezzanoDDecreased platelet counts and decreased platelet serotonin in poststreptococcal nephritis.Nephron1995;
69:
135–9
31.
SinghKSPMisraSSBhargavaKP5-Hydroxytryptamine content of cerebrospinal fluid in leprosy.Nature1965;
206:
206–7
32.
IaconoRPKuniyoshiSMAhlmanJRZimmermanGJMaedaGPearlsteinRDConcentrations of indoleamine metabolic intermediates in the ventricular cerebrospinal fluid of advanced Parkinson's patients with severe postural instability and gait.J Neural Trans1997;
104:
451–9
33.
BrodnerRADohrmannGJRothRKRubinRACorrelation of cerebrospinal fluid serotonin and altered spinal cord blood flow in experimental trauma.Surg Neurol1979;
13:
337–42
34.
LambertGAZagamiASBogdukNLanceJWCervical spinal cord neurons receiving sensory input from the cranial vasculature.Cephalalgia1991;
11:
75–85
35.
Angus-LeppanHOlaussonBBoersPLambertGAConvergence of afferents from superior sagittal sinus and tooth pulp on cells in the upper cervical spinal cord of the cat.Neurosci Lett1994;
182:
275–8
36.
Angus-LeppanHLambertGABoersPLanceJWZagamiASCraniovascular nociceptive pathways relay in the upper cervical spinal cord in the cat.Neurosci Lett1992;
137:
203–6
37.
Angus-LeppanHLambertGAMichalicekJConvergence of occipital nerve and superior sagittal sinus input in the cervical spinal cord of the cat.Cephalalgia1997;
17:
625–30
38.
AnthonyMHinterbergerHLanceJWStudies of serotonin metabolism in migraine.Proc Aust Assoc Neurol1968;
5:
109–12
39.
VanhouttePMCardiovascular effects of serotonin.J Cardiovasc Pharmacol1987;
10Suppl 3:
S8–11
40.
MichalicekJLambertGAGordonVReactions of the middle meningeal artery of the cat to neural and humoral stimulation.Cephalalgia1996;
16:
27–36
41.
RicciopoNFThe depolarising action of 5-HT on mammalian non-myelinated nerve fibres.Eur J Pharmacol1978;
49:
351–6
42.
O'ShaughnessyCTConnorHEFeniukWExtracellular recordings of membrane potential from guinea-pig isolated trigeminal ganglion: lack of effect of sumatriptan.Cephalalgia1993;
13:
175–9
43.
ElamRBergmannFFeuersteinGInteraction of thyrotropinreleasing hormone (TRH) and serotonin in cardiovascular control.Eur J Pharmacol1988;
154:
19–25
44.
ErspamerVOccurrence of indolealkylamines in nature. In:
Handbuch der Experimentellen Pharmakologie.
New York:
Springer-Verlag,
1966:
132–81
45.
LexchinJLCude-SimpsonKDStangerHCBrain and blood indole metabolites after peripheral administration of 14C-5HT in rat.Neurochem Res1977;
2:
39–50
46.
BulatMSupekZPassage of 5-hydroxtryptamine through the blood-brain barrier, its metabolism in the brain and elimination of 5-hydroxyindoleacetic acid from the brain tissue.J Neurochem1967;
15:
383–9
PortasCMThakkarMRainnieGMccarleyRWMicrodialysis perfusion of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) in the dorsal raphe decreases serotonin release and increases rapid eye movement sleep in the freely moving cat.J Neurosci1996;
16:
2820–8
49.
MoskowitzMALiebmannJEReinhardJFJSchlosbergARaphe origin of serotonin-containing neurons within choroid plexus of the rat.Brain Res1979;
169:
590–4
50.
VerheyenAVlaminckxELauwersFBorgersMWoutersLRadioactive colloidal gold as a tool to quantify extravasation of macromolecules in the rat cremaster muscle.Int J Microcirc Clin Exp1987;
5:
321–33
51.
BoersPDonaldsonCZagamiASLambertGAAlniditan modulates the trigeminovascular system by an action at 5HT 1B/1D receptors.Cephalalgia1998;
18:
400
52.
HoyerDClarkeDEFozardJHHartigPBMartinGRMylecharaneEJVII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin).Pharmacol Rev1994;
46:
157–203
53.
AimoneLDJonesSLGebhartGFStimulation-produced descending inhibition from the periaqueductal gray and nucleus raphe magnus in the rat: mediation by spinal monoamines but not opioids.Pain1987;
31:
123–36
54.
JanssAJGebhartGFSpinal monoaminergic receptors mediate the antinociception produced by glutamate in the medullary lateral reticular nucleus.J Neurosci1987;
7:
2862–73
55.
CarstensEFraunhofferMZimmermannMSerotonergic mediation of descending inhibition from midbrain periaqueductal gray but not reticular formation on spinal nociceptive transmission in the cat.Pain1981;
10:
149–67
